Gehören Sie zu den Ersten, denen das gefällt!
Assessment of the “Mode of Action Landscape” for particular disease areas is of high interest for pharmaceutical companies. To enable identification of upcoming, established and vanishing modes of action over time and clinical phases it is crucial to have tools for integration and comparison of drug pipeline data from various sources, including informative visualizations of changes in the landscape.
The BizInt Smart Charts product family including VantagePoint - Smart Charts Edition (VP-SCE) enables these analyses and was therefore selected for evaluation. Data was integrated from different key drug pipeline databases, and the newly developed VP-SCE provided opportunities to use in-house data for normalization of important field content such as the highly diverse lists of “Mode of Action” generated by the pipeline databases. Using an example of pipeline data in the field of breast cancer we will show how the data was curated and processed to reach the final landscape, and how the programs can be applied in the most effective way. Examples of visualizations for facilitated decision-making will also be shown. To this end, our presentation will provide insight on the value of integrating and visualizing both external and internal data from drug pipelines employing these tools.